Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cronos Australia Ltd. ( (AU:VIT) ) just unveiled an update.
Vitura Health Limited has announced the formation of an Industry Advisory Group to enhance its clinical governance and patient experiences. Chaired by Gerard Fogarty, the group will advise on medical practice management and emerging opportunities in the medicinal cannabis and specialty clinics industry, aiming to maintain industry-leading standards and improve patient outcomes.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX. It operates several businesses, including Burleigh Heads Cannabis, which manages the Canview platform for medicinal cannabis distribution, and Doctors on Demand, a telehealth service. The company also has a joint venture with PharmAla Biotech for psychedelic products and owns CDA Clinics and Cannadoc Health, both providing telehealth consultations for medicinal cannabis.
Average Trading Volume: 251,699
Technical Sentiment Signal: Hold
Current Market Cap: A$43.74M
See more data about VIT stock on TipRanks’ Stock Analysis page.